Presentation1_Ginger Constituent 6-Shogaol Inhibits Inflammation- and Angiogenesis-Related Cell Functions in Primary Human Endothelial Cells.pdf
Rhizomes from Zingiber officinale Roscoe are traditionally used for the treatment of a plethora of pathophysiological conditions such as diarrhea, nausea, or rheumatoid arthritis. While 6-gingerol is the pungent principle in fresh ginger, in dried rhizomes, 6-gingerol is dehydrated to 6-shogaol. 6-Shogaol has been demonstrated to exhibit anticancer, antioxidative, and anti-inflammatory actions more effectively than 6-gingerol due to the presence of an electrophilic Michael acceptor moiety. In vitro, 6-shogaol exhibits anti-inflammatory actions in a variety of cell types, including leukocytes. Our study focused on the effects of 6-shogaol on activated endothelial cells. We found that 6-shogaol significantly reduced the adhesion of leukocytes onto lipopolysaccharide (LPS)-activated human umbilical vein endothelial cells (HUVECs), resulting in a significantly reduced transmigration of THP-1 cells through an endothelial cell monolayer. Analyzing the mediators of endothelial cell–leukocyte interactions, we found that 30 µM of 6-shogaol blocked the LPS-triggered mRNA and protein expression of cell adhesion molecules. In concert with this, our study demonstrates that the LPS-induced nuclear factor κB (NFκB) promoter activity was significantly reduced upon treatment with 6-shogaol. Interestingly, the nuclear translocation of p65 was slightly decreased, and protein levels of the LPS receptor Toll-like receptor 4 remained unimpaired. Analyzing the impact of 6-shogaol on angiogenesis-related cell functions in vitro, we found that 6-shogaol attenuated the proliferation as well as the directed and undirected migration of HUVECs. Of note, 6-shogaol also strongly reduced the chemotactic migration of endothelial cells in the direction of a serum gradient. Moreover, 30 µM of 6-shogaol blocked the formation of vascular endothelial growth factor (VEGF)-induced endothelial sprouts from HUVEC spheroids and from murine aortic rings. Importantly, this study shows for the first time that 6-shogaol exhibits a vascular-disruptive impact on angiogenic sprouts from murine aortae. Our study demonstrates that the main bioactive ingredient in dried ginger, 6-shogaol, exhibits beneficial characteristics as an inhibitor of inflammation- and angiogenesis-related processes in vascular endothelial cells.
History
References
- https://doi.org//10.3389/fonc.2019.01399
- https://doi.org//10.1007/s10059-009-0026-y
- https://doi.org//10.1084/jem.185.1.111
- https://doi.org//10.1155/2014/159089
- https://doi.org//10.1016/j.fct.2007.09.085
- https://doi.org//10.1016/j.biopha.2017.12.009
- https://doi.org//10.1007/s11418-010-0404-y
- https://doi.org//10.1038/nprot.2011.435
- https://doi.org//10.1055/a-1351-1038
- https://doi.org//10.1016/j.yjmcc.2019.08.001
- https://doi.org//10.1016/j.jep.2009.10.004
- https://doi.org//10.1074/jbc.M101985200
- https://doi.org//10.1089/jmf.2009.1239
- https://doi.org//10.18632/oncotarget.16719
- https://doi.org//10.1152/ajprenal.00182.2019
- https://doi.org//10.3390/molecules23020466
- https://doi.org//10.1172/JCI107470
- https://doi.org//10.1016/j.phytochem.2005.05.007
- https://doi.org//10.1016/j.bbrep.2021.101046
- https://doi.org//10.1039/c7fo01354j
- https://doi.org//10.1096/fj.202100037R
- https://doi.org//10.1186/1471-2210-6-12
- https://doi.org//10.1002/mnfr.201400791
- https://doi.org//10.1242/jcs.048942
- https://doi.org//10.1515/bchm.1997.378.9.951
- https://doi.org//10.1039/d0fo02834g
- https://doi.org//10.1016/j.ijcard.2007.07.107
- https://doi.org//10.3390/molecules24203705
- https://doi.org//10.1080/10408398.2011.553751
- https://doi.org//10.1002/mnfr.200700515
- https://doi.org//10.1155/2015/142979
- https://doi.org//10.1021/jf9027443
- https://doi.org//10.4049/jimmunol.179.11.7840
- https://doi.org//10.3109/08923973.2013.782318
- https://doi.org//10.1096/fj.201802440R
- https://doi.org//10.1248/bpb1978.7.836
- https://doi.org//10.1016/j.ijpharm.2018.08.028
- https://doi.org//10.1155/2013/503521
- https://doi.org//10.1002/mnfr.201200173
- https://doi.org//10.1016/s0008-6363(02)00512-6
- https://doi.org//10.3390/pharmaceutics11030107
- https://doi.org//10.1186/s13046-019-1291-z